{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2014:OYUNQD5N3Q5MVQO7Q4STFE6VA4","short_pith_number":"pith:OYUNQD5N","schema_version":"1.0","canonical_sha256":"7628d80faddc3acac1df87253293d5070113bd496d9af61ac7578118c80e4823","source":{"kind":"arxiv","id":"1410.0762","version":1},"attestation_state":"computed","paper":{"title":"Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"q-bio.QM","authors_text":"Ahmad Amanzada, Christian R\\\"over, Nicolae-Catalin Mechie, Silke Cameron","submitted_at":"2014-10-03T06:48:20Z","abstract_excerpt":"AIM: To investigate the predictability of interleukin-28B single nucleotide polymorphism rs12979860 with respect to sustained virological response (SVR) in chronically hepatitis C virus (HCV) genotype-1 patients treated with a protease-inhibitor and pegylated interferon-$\\alpha$ (Peg-INF-$\\alpha$) based triple-therapy.\n  METHODS: We searched PubMed, the Cochrane Library and Web of Knowledge for studies regarding the interleukin 28B (IL-28B)-genotype and protease-inhibitor based triple-therapy. Ten studies with 2707 patients were included into this meta-analysis. We used regression methods in o"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1410.0762","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2014-10-03T06:48:20Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"f259b68de4a1d507e2b38ad411b98f98a56fc2d76b0342fc87e6affed2402e80","abstract_canon_sha256":"85f0492bb978217fc9e0d1f3072e994680c2d320e5ca4759da87b2b6737431cd"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T02:37:51.381172Z","signature_b64":"5HQGkZFQ5ds1YF1Sq+ralPnrIfU7ja6wotoc/lleODHxcFMH+kCYlqVbABCjjVD9vBX5tUdZc4YmJ8gGeuLsDQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"7628d80faddc3acac1df87253293d5070113bd496d9af61ac7578118c80e4823","last_reissued_at":"2026-05-18T02:37:51.380625Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T02:37:51.380625Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"q-bio.QM","authors_text":"Ahmad Amanzada, Christian R\\\"over, Nicolae-Catalin Mechie, Silke Cameron","submitted_at":"2014-10-03T06:48:20Z","abstract_excerpt":"AIM: To investigate the predictability of interleukin-28B single nucleotide polymorphism rs12979860 with respect to sustained virological response (SVR) in chronically hepatitis C virus (HCV) genotype-1 patients treated with a protease-inhibitor and pegylated interferon-$\\alpha$ (Peg-INF-$\\alpha$) based triple-therapy.\n  METHODS: We searched PubMed, the Cochrane Library and Web of Knowledge for studies regarding the interleukin 28B (IL-28B)-genotype and protease-inhibitor based triple-therapy. Ten studies with 2707 patients were included into this meta-analysis. We used regression methods in o"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1410.0762","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1410.0762","created_at":"2026-05-18T02:37:51.380717+00:00"},{"alias_kind":"arxiv_version","alias_value":"1410.0762v1","created_at":"2026-05-18T02:37:51.380717+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1410.0762","created_at":"2026-05-18T02:37:51.380717+00:00"},{"alias_kind":"pith_short_12","alias_value":"OYUNQD5N3Q5M","created_at":"2026-05-18T12:28:43.426989+00:00"},{"alias_kind":"pith_short_16","alias_value":"OYUNQD5N3Q5MVQO7","created_at":"2026-05-18T12:28:43.426989+00:00"},{"alias_kind":"pith_short_8","alias_value":"OYUNQD5N","created_at":"2026-05-18T12:28:43.426989+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4","json":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4.json","graph_json":"https://pith.science/api/pith-number/OYUNQD5N3Q5MVQO7Q4STFE6VA4/graph.json","events_json":"https://pith.science/api/pith-number/OYUNQD5N3Q5MVQO7Q4STFE6VA4/events.json","paper":"https://pith.science/paper/OYUNQD5N"},"agent_actions":{"view_html":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4","download_json":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4.json","view_paper":"https://pith.science/paper/OYUNQD5N","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1410.0762&json=true","fetch_graph":"https://pith.science/api/pith-number/OYUNQD5N3Q5MVQO7Q4STFE6VA4/graph.json","fetch_events":"https://pith.science/api/pith-number/OYUNQD5N3Q5MVQO7Q4STFE6VA4/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4/action/timestamp_anchor","attest_storage":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4/action/storage_attestation","attest_author":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4/action/author_attestation","sign_citation":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4/action/citation_signature","submit_replication":"https://pith.science/pith/OYUNQD5N3Q5MVQO7Q4STFE6VA4/action/replication_record"}},"created_at":"2026-05-18T02:37:51.380717+00:00","updated_at":"2026-05-18T02:37:51.380717+00:00"}